SCHEMBL16213688

SCHEMBL16213688

COC(CCCNC(=O)c1ccc(CN)cc1)OC

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.53
▸ LOXL2 Q9Y4K0 4/20 0.50
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ MCHR1 Q99705 1/20 0.48
▸ HDAC3 O15379 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ NCOR2 Q9Y618 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.43
▸ LOX P28300 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ PRMT1 Q99873 1/20 0.43
▸ ESRRG P62508 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9313528 0.90 ALDH1A1 (0.64) ALDH1A1NPC1RAB9APOLBTSHR
SCHEMBL16213694 0.87 ALDH1A1 (0.54) ALDH1A1NPC1RAB9AHDAC3POLB
SCHEMBL9313118 0.81 SMN1; SMN2 (0.62) ALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL8269347 0.81 MCHR1 (0.48) ALDH1A1LOXL2NPC1RAB9AMCHR1
SCHEMBL8234410 0.80 HDAC3 (0.61) ALDH1A1LOXL2NPC1RAB9AMCHR1
SCHEMBL29300416 0.80 NPC1 (0.51) ALDH1A1NPC1RAB9AMCHR1HDAC3
SCHEMBL19634404 0.79 LOXL2 (0.64) ALDH1A1LOXL2NPC1MCHR1HDAC3
SCHEMBL8122188 0.79 SMN1; SMN2 (0.63) ALDH1A1LOXL2NPC1RAB9AMCHR1
SCHEMBL20031964 0.79 HDAC3 (0.59) ALDH1A1LOXL2NPC1RAB9AMCHR1
SCHEMBL8269538 0.78 L3MBTL1 (0.67) ALDH1A1NPC1RAB9AMCHR1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718280-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMA SPA (IT) 2015-09-16 — — EP disclosed
US-8877774-B2 Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity CHIESI FARMACEUTICI S.P.A. (IT) 2014-11-04 — — US disclosed
US-8877774-B2 Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity CHIESI FARMACEUTICI S.P.A. (IT) 2014-11-04 — — US disclosed
Send feedback